Öztürk, E. Et Al. 2023. Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach. DIAGNOSTICS , vol.13, no.4 , 709-720.

Öztürk, E., Esenboga, K., Kurtul, A., Kilickap, M., Karaagaoglu, E., & Karakaya, J., (2023). Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach. DIAGNOSTICS , vol.13, no.4, 709-720.

Öztürk, EBRU Et Al. "Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach," DIAGNOSTICS , vol.13, no.4, 709-720, 2023

Öztürk, EBRU Et Al. "Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach." DIAGNOSTICS , vol.13, no.4, pp.709-720, 2023

Öztürk, E. Et Al. (2023) . "Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach." DIAGNOSTICS , vol.13, no.4, pp.709-720.

@article{article, author={EBRU ÖZTÜRK Et Al. }, title={Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach}, journal={DIAGNOSTICS}, year=2023, pages={709-720} }